Location History:
- Wallingford, CT (US) (1992)
- Waterford, CT (US) (1997)
Company Filing History:
1 out of 3,684 
1 out of 41 Years Active: 1992-1997
Title: The Innovations of Thomas T Dabrah
Introduction
Thomas T Dabrah is a notable inventor based in Wallingford, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor antibiotics. With a total of 2 patents, his work has had a meaningful impact on cancer treatment.
Latest Patents
Dabrah's latest patents include novel antitumor depsipeptides produced by Micromonospora strain 39500, ATCC 55011. These compounds have specific structural formulas that contribute to their effectiveness. Another significant patent is for the antitumor antibiotic designated BMY-42428, which is produced by fermentation of Actinomadura madurae ATCC-53806. This antibiotic exhibits both antimicrobial and antitumor activities, showcasing Dabrah's innovative approach to combating cancer.
Career Highlights
Throughout his career, Dabrah has worked with prominent companies such as Bristol-Myers Squibb Company. His experience in the pharmaceutical industry has allowed him to develop groundbreaking treatments that address critical health issues.
Collaborations
Dabrah has collaborated with notable coworkers, including Grace A Hesler and Kin S Lam. These partnerships have likely contributed to the success of his inventions and patents.
Conclusion
Thomas T Dabrah's contributions to the field of pharmaceuticals, particularly in antitumor antibiotics, highlight his innovative spirit and dedication to improving healthcare. His work continues to influence cancer treatment and showcases the importance of research and development in medicine.